The 2026 Launch Blitz: Model Family, Voice Mode, Epic Deals, a $15B Round and a Drug-Development Pivot

A tour of what OpenEvidence shipped and signed in 2026: the Osler/Sackett/Snow/Darwin model family, Voice Mode, enterprise Epic integrations at NYU Langone, MSK, Penn, Cedars-Sinai and AdventHealth, the Anthropic global partnership, and Nadler's plan to put a drug into clinical trials. Candidates who can discuss these specifics stand out immediately.